Strategies for Clinical Implementation of Screening for Hereditary Cancer Syndromes

Hereditary cancer syndromes generally account for 5-10% of malignancies. While these syndromes are rare, affected patients carry significantly elevated risks of developing cancer, as do their at-risk relatives. Identification of these patients is critical to ensure timely and appropriate genetic testing relevant to cancer patients and their relatives. Several guidelines and tools are available to assist clinicians. Patients suspected to have hereditary cancer syndromes should be offered genetic testing in the setting of genetic counseling by a qualified genetics professional.
Source: Seminars in Oncology - Category: Cancer & Oncology Authors: Source Type: research